Christopher B. Primiano
2018
In 2018, Christopher B. Primiano earned a total compensation of $1.5M as Executive Vice President, Chief Business Officer, General Counsel and Secretary at Karyopharm Therapeutics, a 5% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $204,020 |
|---|---|
| Option Awards | $902,913 |
| Salary | $404,000 |
| Other | $11,660 |
| Total | $1,522,593 |
Primiano received $902.9K in option awards, accounting for 59% of the total pay in 2018.
Primiano also received $204K in non-equity incentive plan, $404K in salary and $11.7K in other compensation.
Rankings
In 2018, Christopher B. Primiano's compensation ranked 7,090th out of 14,244 executives tracked by ExecPay. In other words, Primiano earned more than 50.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,090 out of 14,244 | 50th |
Division Manufacturing | 2,725 out of 5,762 | 53rd |
Major group Chemicals And Allied Products | 1,027 out of 2,125 | 52nd |
Industry group Drugs | 866 out of 1,814 | 52nd |
Industry Pharmaceutical Preparations | 676 out of 1,388 | 51st |
Source: SEC filing on April 19, 2019.
Primiano's colleagues
We found four more compensation records of executives who worked with Christopher B. Primiano at Karyopharm Therapeutics in 2018.
2018
Anand Varadan
Karyopharm Therapeutics
Executive Vice President, Chief Commercial Officer
2018
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
2018
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
2018
Michael MSM
Karyopharm Therapeutics